“…These studies included between 90 and 4,841 patients followed up for up to 14 years [33,[38][39][40][41][42]. They confirmed that HBeAg seroconversion occurred at a significantly younger age for those infected with genotype B than genotype C [15,38,40,42] and that increased risk of fibrosis was associated with genotype C [39,40]. The two largest studies, consisting of 426 and 4,841 patients followed up for a mean of 4.8 and 14 years, respectively, showed a significant increase in risk for HCC in genotype C in comparison with genotype B [33,[38][39][40][41][42].…”